Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prohibition Partners is a premier market intelligence and strategic consultancy firm dedicated to the global cannabis and psychedelic industries. The company provides high-quality data, insights, and advisory services to a diverse clientele, including investors, healthcare operators, and government regulators. By publishing influential industry reports and hosting international conferences like Cannabis Europa, they play a critical role in shaping the legal and commercial landscape of medical cannabis and psychedelic medicine. Their expertise helps stakeholders navigate complex regulatory environments and identify emerging opportunities in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prohibition Partners.